| scholarly article | Q13442814 |
| P356 | DOI | 10.1136/ARD.29.5.537 |
| P8608 | Fatcat ID | release_ec45catzhjg37cafrrf623yg44 |
| P953 | full work available at URL | https://europepmc.org/articles/PMC1010569 |
| https://europepmc.org/articles/PMC1010569?pdf=render | ||
| https://syndication.highwire.org/content/doi/10.1136/ard.29.5.537 | ||
| P932 | PMC publication ID | 1010569 |
| P698 | PubMed publication ID | 5476681 |
| P5875 | ResearchGate publication ID | 17695750 |
| P2093 | author name string | J. Becker | |
| C. F. Hawkins | |||
| R. Cockel | |||
| M. J. Kendall | |||
| P2860 | cites work | Serum 5-nucleotidase | Q28212243 |
| AMYLOIDOSIS IN RHEUMATOID ARTHRITIS INVESTIGATED BY MEANS OF RECTAL BIOPSY. | Q33626152 | ||
| The Liver in Rheumatoid Arthritis | Q41344259 | ||
| Amyloidosis in rheumatoid arthritis treated with hormones | Q41362888 | ||
| The bromsulphalein retention as index for the activity of chronic polyarthritis | Q43697687 | ||
| Serum alkaline phosphatase in rheumatic diseases and its influencing by corticosteroids | Q43974891 | ||
| Liver in Felty's Syndrome | Q71410425 | ||
| Rheumatoid liver? | Q71516544 | ||
| An assessment of 5'-nucleotidase as a liver-function test | Q72361168 | ||
| On amyloidosis and other causes of death in rheumatoid arthritis | Q73706502 | ||
| Rheumatoid arthritis and rheumatoid disease | Q74582045 | ||
| LIVER FUNCTION IN RHEUMATOID ARTHRITIS | Q77080147 | ||
| DIAGNOSTIC criteria for rheumatoid arthritis: 1958 revision by a committee of the American Rheumatism Association | Q78637722 | ||
| The liver cell. Some new approaches to its study | Q78848714 | ||
| P433 | issue | 5 | |
| P407 | language of work or name | English | Q1860 |
| P921 | main subject | immunology | Q101929 |
| rheumatology | Q327657 | ||
| P304 | page(s) | 537-540 | |
| P577 | publication date | 1970-09-01 | |
| P1433 | published in | Annals of the Rheumatic Diseases | Q4767876 |
| P1476 | title | Raised serum alkaline phosphatase in rheumatoid disease. An index of liver dysfunction? | |
| P478 | volume | 29 |
| Q41116574 | 5' nucleotidase activity in the human synovial lining in rheumatoid arthritis |
| Q54580791 | 5-nucleotidase in the serum and synovial fluid of patients with rheumatoid disease. |
| Q33565591 | Alkaline phosphatase isoenzyme activities in rheumatoid arthritis: hepatobiliary enzyme dissociation and relation to disease activity |
| Q69609952 | Alkaline phosphatase isoenzymes in rheumatic diseases |
| Q33569650 | Assessment of rheumatoid activity based on clinical features and blood and synovial fluid analysis |
| Q72417664 | Biochemical and clinical changes in rheumatoid arthritis: Their relation to the action of antirheumatoid drugs |
| Q27469289 | Clinical associations between arthritis and liver disease |
| Q33552557 | Discriminatory indices of response of patients with rheumatoid arthritis treated with D-penicillamine |
| Q41202496 | Effect of auranofin on plasma fibronectin, C reactive protein, and albumin levels in arthritic rats |
| Q33551599 | Gamma glutamyl transpeptidase levels in arthritis: a correlation with clinical and laboratory indices of disease activity |
| Q37825811 | Gastrointestinal and hepatic manifestations of rheumatoid arthritis |
| Q53822206 | Haematology and biochemistry of ankylosing spondylitis. |
| Q41919996 | Hepatotoxic effects of anti-rheumatic drugs in cultured rat hepatocytes |
| Q42219349 | Hepatotoxicity associated with low-dose, long-term methotrexate treatment of rheumatoid arthritis |
| Q33554759 | Increased serum alkaline phosphatase activity in ankylosing spondylitis |
| Q33561658 | Influence of non-steroidal anti-inflammatory drugs and disease activity on serum alkaline phosphatase concentrations in rheumatoid arthritis, osteoarthritis, and polymyalgia rheumatica |
| Q40567633 | Interpretation and clinical significance of alkaline phosphatase isoenzyme patterns |
| Q35040109 | Liver abnormalities in rheumatic diseases |
| Q33569166 | Liver disease in patients with joint symptoms |
| Q41927243 | Liver function in some common rheumatic disorders |
| Q69316388 | Long Term Study of Naproxen Challenged by a Short-Term Double Blind Cross-Over Study with Placebo in Rheumatoid Patients |
| Q34743511 | Methotrexate hepatotoxicity |
| Q39514641 | Methotrexate in rheumatoid arthritis. |
| Q66894729 | Naproxen: Long-Term Study in Rheumatoid Arthritis and “Placebo Pulse” |
| Q36282905 | Non-steroidal Anti-inflammatory Drugs: Monitoring to help prevent serious adverse effects |
| Q68774197 | Osteopenia in rheumatoid arthritis: a biochemical, hormonal and histomorphometric study |
| Q33556267 | Raised serum alkaline phosphatase and aspartate transaminase levels in two rheumatoid patients treated with sulphasalazine |
| Q39783106 | Rheumatoid arthritis and liver involvement |
| Q33567771 | Serum biochemical values in rheumatoid disease |
| Q33568593 | Source and significance of 5-nucleotidase in synovial fluid |
| Q31948214 | The glutathione defense system in the pathogenesis of rheumatoid arthritis |
| Q30671609 | The influence of drugs and disease activity on biochemical and haematological data in rheumatoid arthritis |
| Q70526071 | The liver and arthritis |
| Q40317301 | The measurement of serum alkaline phosphatase in clinical medicine. |
| Q33554737 | Thrombocytosis of active rheumatoid disease |
| Q48361047 | Turn-On Colorimetric Platform for Dual Activity Detection of Acid and Alkaline Phosphatase in Human Whole Blood. |
Search more.